Full-Time

Director of Engineering

Data Products

Updated on 8/25/2026

Clover Health

Clover Health

501-1,000 employees

Medicare Advantage insurer with personalized care

Compensation Overview

$223.1k - $290k/yr

Remote in USA

Remote

Category
Data & Analytics (1)
Required Skills
Distributed Systems
Data Engineering
SOC 2
Observability
HIPAA

Get referred to Clover Health

See people who can refer or advise you

Requirements
  • 10+ years of engineering experience with a deep focus on building high-scale data platforms, distributed systems, and interoperability standards such as FHIR and CCDA.
  • A proven track record in managing and scaling engineering teams that handle data-heavy workloads and complex clinical data pipelines.
  • Proven experience leading cross-functional teams of engineers to deliver complex software in regulated environments.
  • Experience implementing and scaling AI-assisted development workflows, such as AI code assistants, automated testing, or AI-driven software development life cycle processes.
  • Demonstrated experience building and managing engineering systems in highly regulated healthcare environments, with a strong operational understanding of HIPAA and SOC 2 compliance requirements.
  • Deep familiarity with the complexities and lack of standardization in clinical datasets, with a focus on enhancing data integrity.
  • Experience directly hiring, mentoring, and developing engineering managers, Tech Leads, and Principal Engineers.
  • Experience cultivating a high-performance engineering culture focused on velocity, quality, and psychological safety.
  • Experience leading organizational change, including structural reorganizations and process evolution.
  • Strong proficiency in strategic resource allocation, capacity planning, and managing technical debt in a fast-paced product environment.
  • Stakeholder management skills, including translating complex technical constraints into clear, actionable business strategies for non-technical leadership.
Responsibilities
  • Own the Data Products technical roadmap, canonical data modeling, and ingestion scalability.
  • Manage and optimize the clinical data ingestion pipeline.
  • Oversee the scaling of customer data onboarding processes and the continuous improvement of data hygiene, canonical storage standards, and observability and monitoring of data pipelines.
  • Enable shared funnel visibility across the organization and support development of an enterprise reporting framework.
  • Drive adoption of an AI-powered software development life cycle, leveraging AI tools to accelerate coding, testing, and deployment while maintaining code quality and security standards.
  • Achieve improved clinical data coverage and freshness targets across patient populations.
  • Establish predictable and repeatable multi-customer scaling with standardized playbooks for rapid data readiness.
  • Drive broad adoption of the Data Products platform and its capabilities.
  • Ensure data infrastructure is robust, stable, and a reliable source of truth during organizational growth and customer expansion.
  • Own the technical strategy and execution for the Data Products roadmap and serve as a partner to engineering, product, data science, and design leaders.
Desired Qualifications
  • Passion for the healthcare sector and commitment to using technical expertise to improve patient outcomes.
  • Motivation to solve intricate technical challenges and architect pragmatic, high-quality engineering solutions through continuous intellectual exploration.
  • Ability to navigate ambiguity and align technical priorities with overarching strategic objectives.
  • Willingness to address operational gaps to ensure the team achieves delivery milestones.

Clover Health provides Medicare Advantage plans for seniors in the United States, offering coverage that goes beyond traditional Medicare. Its services include personalized care, fitness memberships, home checkups, drug coverage, and Medigap insurance, with revenue coming from member premiums and Medicare reimbursements. The product works by enrolling members in Medicare Advantage and delivering added benefits through a network of healthcare providers and fitness centers, plus home visits and proactive support to manage health. The company differentiates itself with a focus on tailored, attentive care and a growing provider network to enhance member benefits, aiming to improve health outcomes. Its primary goal is to help seniors stay healthier and reduce out-of-pocket costs by combining comprehensive coverage with personalized services.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Nashville, Tennessee

Founded

2014

Get referred to Clover Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026 guidance rose to $2.92 billion-$3.0 billion revenue and $70-$85 million EBITDA.
  • Q2 2026 membership reached 157,309, up 48%, extending scale across core states.
  • A 4.5-star 2027 payment-year rating supports richer reimbursement and stronger retention.

What critics are saying

  • CMS appealed the July 2026 star-rating ruling; 2027 bonus payments now face reversal.
  • The July 4, 2026 breach exposed member PHI, triggering OCR, lawsuits, and monitoring costs.
  • Q4 2026 seasonal losses and an 86.5% claims ratio keep execution fragile.

What makes Clover Health unique

  • Clover Assistant turns claims data into physician prompts across Medicare Advantage visits.
  • Full-risk Medicare Advantage plus wide-network focus in New Jersey and Georgia differentiates Clover.
  • AI underwriting and home-visit operations combine clinical control with insurance economics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Performance Bonus

Unlimited Paid Time Off

Remote Work Options

Parental Leave

Professional Development Budget

Phone/Internet Stipend

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-1%
Yahoo Finance
Aug 20th, 2026
Clover Health beats Q2 revenue estimates with 55.6% growth to $743M

Clover Health reported Q2 revenues of $743.2 million, up 55.6% year-on-year and exceeding analyst expectations by 2%. The Medicare Advantage provider also beat EPS estimates and issued full-year EBITDA guidance above analyst expectations. "Our results demonstrate that a wide-network, full-risk Medicare Advantage model can deliver better health outcomes, meaningful growth, and increasing profitability at the same time," said CEO Andrew Toy. The company's shares rose 1.9% following the results and currently trade at $4.22. This performance stood out amongst the 12 health insurance providers tracked, which collectively saw share prices fall 6.2% since their latest earnings despite revenues beating consensus estimates by 2.8%.

Yahoo Finance
Aug 14th, 2026
Clover Health beats Q2 estimates with $743M revenue, raises full-year guidance as AI platform drives growth

Clover Health reported second-quarter results that exceeded analyst expectations, with revenue of $743.2 million beating estimates by 2% and adjusted EBITDA of $40.92 million surpassing forecasts by 34.7%. The Medicare Advantage insurer's membership grew to 157,309, up from 155,773 in the previous quarter. CEO Andrew Toy attributed the performance to the company's Clover Assistant AI platform and disciplined market focus in New Jersey and Georgia. He emphasised that "better clinical care leads to stronger cohort economics." The company raised its full-year revenue guidance to $2.96 billion from $2.87 billion, a 3.3% increase. EBITDA guidance of $77.5 million exceeded analyst estimates of $58.44 million. Operating margin improved to 3.8%, up from negative 2.2% in the same quarter last year. Management credited favourable medical cost trends and improved operating leverage.

Yahoo Finance
Aug 13th, 2026
Clover Health grows MA membership 48% while boosting net income $67M in first half of 2026

Clover Health reported strong performance in the first half of 2026, with Medicare Advantage membership growing 48% and GAAP net income increasing by $67 million year-over-year. Chief executive officer Andrew Toy highlighted the company's focus on using AI to improve physician decision-making through its Clover Assistant platform. The earnings call, held on 5 August 2026, emphasised how technology-driven improvements in patient care can drive both membership growth and profitability simultaneously. Toy stated that Clover's approach centres on helping physicians make better decisions for individual patients, rather than simply making the healthcare system marginally more efficient. The results demonstrate the company's progress in scaling its AI-assisted healthcare model across its Medicare Advantage business.

Yahoo Finance
Aug 6th, 2026
Clover Health raises 2026 outlook as Medicare membership surges 48% to 157K

Clover Health reported strong second-quarter results, with Medicare Advantage membership rising 48% year-over-year to 157,000 and revenue growing 56% to $743 million. The company generated $41 million in adjusted EBITDA and $28 million in GAAP net income, ending the quarter with $443 million in cash and no debt. The health insurer raised its full-year 2026 outlook for membership, revenue, gross profit, adjusted EBITDA and GAAP net income. Management expects positive adjusted EBITDA in the third quarter but anticipates a seasonal loss in Q4. Consolidated gross profit reached $153 million, up 54% from last year. All members are now enrolled in plans rated 4.5 stars for the 2027 payment year, though the Centers for Medicare & Medicaid Services plans to appeal the related court decision.

Yahoo Finance
Aug 5th, 2026
Clover Health revenue jumps 55.6% to $743M, beats Q2 estimates and raises full-year guidance

Clover Health reported second-quarter revenue of $743.2 million, beating analyst estimates of $728.2 million and marking 55.6% year-on-year growth. The health insurance company's shares rose 10.3% following the announcement. The company posted GAAP earnings of $0.05 per share, surpassing consensus estimates of $0.03. Adjusted EBITDA reached $40.92 million, exceeding expectations of $30.38 million by 34.7%. Clover Health raised its full-year revenue guidance to $2.96 billion at the midpoint, up from $2.87 billion previously. Full-year EBITDA guidance of $77.5 million also came in above analyst estimates of $58.44 million. The company's customer base grew to 157,309, up from 155,773 in the previous quarter. Operating margin improved to 3.8%, compared with negative 2.2% in the same period last year.